Early diagnosis of early stage lung cancer
Abstract
Background: For the detection of premalignant changes of bronchial mucosa and early stages of lung cancer frequent chest X-ray, spiral low dose computed tomography, fluorescence bronchoscopy, sputum cytology (also with automated systems) with genetic and molecular changes in the sputum cells and bronchial mucosa were used. These screening methods of the high-risk groups for lung cancer achieved: earlier diagnosis of lung cancer in lower stage, higher operability, longer 5-year survival, but without mortality reduction.
Conclusions: In the clinical practice we can examine higher risk groups for lung cancer in randomised control trials with multimodality approach: frequent chest low-dose fast spiral computed tomography, sputum cytology with genetic and molecular examinations and fluorescence bronchoscopy. Smoking cessation remains the best means to achieve mortality reduction from lung cancer.
Downloads
References
Skuladottir H, Olsen JH. Epidemiology of lung cancer. Eur Respir Mon 2001; 17: 1–12.
Pompe-Kirn V, Zakotnik B, Zadnik V. Preživetje bolnikov z rakom v Sloveniji 1983–1997: register raka za Slovenijo. Ljubljana: Onkološki inštitut; 2003.
Debeljak A, Triller N, Kecelj P, Pompe-Kirn V, Rott T, Osolnik K, et al. Smernice za internistično obravnavo bolnika s pljučnim rakom. Zdrav Vestn 2001; 70: 751–70.
Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J Clin Oncol 1993; 11: 1216–24.
Ziegler RG, Subar AF, Craft NE, Ursin G, Patterson BH, Graubard BI. Does beta-caroten explain why reduced cancer risk is associated with vegetable and fruit intake? Cancer Res 1992; 52 Suppl 7: 2060s–6s.
Menkes MS, Comstock GW, Vuilleumier JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-caroten, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 1986; 315: 1250–7.
Anon. The alpha-tocopherol, beta-carotene cancer prevention study group: the effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1029–35.
Strauss GM. The case in favor of lung cancer screening. In: Up To Date 2003; 11(2): www.uptodate.com (800) 998–6374, (781) 237–4788.
Tršinar B. Presejanje in zgodnje odkrivanje raka prostate. In: Primc-Žakelj M, ed. Posvetovanje o državnem programu nadzorovanja raka. Ljubljana: Onkološki inštitut, Ministrstvo za zdravstvo RS Slovenije; 1996.
Mandel J. Screening for lung cancer. In: Up To Date 2003; 11(2): www.uptodate.com (800) 998–6374, (781) 237–4788.
Mountain CF. Revisions in the international system for the staging of lung cancer. Chest 1997; 111: 1710–7.
Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax 1968; 23: 414–20.
Wilde JA. 10 year follow up of semiannual screening for early detection of lung cancer in the Erfurt county, GDR. Eur Respir J 1989; 2: 656–62.Salomaa ER, Liippo K, Taylor P, Palmgren J, Haapakoski J, Virtamo J, et al. Prognosis of patients with lung cancer found in a single chest radiograph screening. Chest 1998; 114: 1514–8.
Frost JK, Ball WC Jr, Levin ML, Tockman MS, Baker RR, Carter D, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins Study. Am Rev Respir Dis 1984; 130: 549–54.
Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Perchick WB, Martini N. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis 1984; 130: 555–60.
Fontana RS, Sanderson DR, Taylor WF, Woolner LB, Miller WE, Muhm JR, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic Study. Am Rev Respir Dis 1984; 130: 561–5.
Kubik A, Parkin DM, Khlat M, Erban M, Polak J, Adamec M. Lack of benefit from semi-annual screening for lung cancer of the lung: follow up report of a randomised controlled trial on a population of high risk males in Czechoslovakia. Int J Cancer 1990; 45: 26–33.
Quekel LGBA, Kessels AGH, Goei R, van Engelshoven JMA. Miss rate of lung cancer on the chest radiograph in clinical practice. Chest 1999; 115: 720–4.
Rusinek H, Naidich DP, McGuinness G, Leitman BS, McCauley DI, Krinsky GA, et al. Pulmonary nodule detection: low-dose versus conventional CT. Radiology 1998; 209: 243–9.
Kaneko M, Eguchi K, Ohmatsu H, Kakinuma R, Naruke T, Suemasu K, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 1996; 201: 798–802.
Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351: 1242–5.
Henschke CI, McCauley D, Yankelevitz. Early Lung Cancer Action Project: findings from repeat annual screening. Am J Respir Crit Care Med 2000; 161: A13.
Jett JR, Swensen SJ, Midthun DE. Screening for lung cancer: Mayo Clinic study with low dose spiral CT scan and sputum cytology (prevalence screen). Am J Respir Crit Care Med 2000; 161: A13.
Gohagan JK, Marcus PM, Fagerstrom RM, Pinsky PF, Kramer BS, Prorok PC, et al. Final results of the lung screening study, a randomised feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer 2005; 47: 9–15.
Tockman MS, Gupta PK, Myers JD, Frost JK, Baylin SB, Gold EB, et al. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J Clin Oncol 1988; 6: 1685–93.
Tockman MS. Survival and mortality from lung cancer in a screened population. The Johns Hopkins study. Chest 1986; 89 Suppl 7: 324–5S.
Midthun DE, Jett JR. Screening for lung cancer. Eur Respir Mon 2001; 17: 71–85.
Phillips M, Gleeson K, Hughes JMB, Greenberg J, Cataneo RN, Baker L, McVay WP. Volatile organic compounds in breath as markers of lung cancer: A cross-sectional study. Lancet 1999; 353: 1930–33.
Woolner LB, Fontana RS, Cortese DA. Roentgenographically occult lung cancer: Pathologic findings and frequency of multicentricity during a 10year period. Mayo Clin Proc 1984; 59: 543–66.
Lam S, MacAulay C, LeRichie JC. Early localisation of bronchogenic carcinoma. Diagn Therapeutic Endosc 1994; 1: 75–8.
Kurie JM, Lee JS, Morice RC, Walsh GL, Khuri FR, Broxson A, et al. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Nat Cancer Instit 1998; 90: 991–5.
Shaw GL, Walsh FW, Rolfe MW, Cantor AB, Vann V, Khoor A. Value of fluorescent bronchoscopy in identifying bronchial metaplasia and dysplasia in smokers. Proc of ASCO 1999; 18: 476a.
Sutedja TG, Venmans BJ, Smith EF, Postmus PE. Fluorescence bronchoscopy for early detection of lung cancer. A clinical perspective. Lung Cancer 2001; 34: 157–68.
Debeljak A, Triller N, Kecelj P, Kern I. Avtofluorescenčna bronhoskopija v diagnostiki preneoplastičnih sprememb in bronhialnega karcinoma. Zdrav Vestn 2002; 71: 449–52.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
